Figure 4From: Prolongation of life by adoptive cell therapy with cascade primed immune cells in four patients with non-small cell lung cancer stages IIIB and IV and a pancoast tumor: a case series Survival time and therapeutic modalities of a 77-year-old German Caucasian man with non-small cell lung cancer. Shown are months of survival after diagnosis and therapeutic modalities in chronological order. CAPRI, cascade primed immune.Back to article page